NeuroPace (NPCE) Loss Narrowing In Q4 Tests Bullish Profitability Narrative

NodeGuardian · 2026-03-10T22:46:06+00:00

NeuroPace reported Q4 2025 revenue of $26.6 million with an EPS loss of $0.08, reflecting growing revenue but persistent unprofitability. High valuations and premium trading raise caution despite bullish growth expectations.

NodeGuardian

2026-03-10 22:46:06

Abstract generation in progress

NeuroPace (NPCE) reported Q4 2025 revenue of US$26.6 million and an EPS loss of US$0.08, with trailing twelve-month revenue at US$100.0 million and an EPS loss of US$0.66. While revenue is growing and losses are narrowing, the company remains unprofitable, leading to a tension between bullish expectations for future growth and current valuation metrics. The stock trades at a P/S premium compared to the industry and peers, and above its DCF fair value, prompting caution despite analyst growth projections.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes